Litts Drug Eruption & Reaction Database - Presented by CRC Press

Nothing else can remotely compare to it.Patricia Wong, MD, Stanford University Medical Centre


Log in
In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Continue
Menu
Login
  • Home
  • About About
    • About the Database
    • About the Book
    • Related Products
    • About Dr Litt
    • About Dr Shear
  • Alerts
  • Litt’s App
  • Contact Us
  • Help
  • Subscribe Subscribe
    • Individual Subscription
    • Institutional Subscription

Quinapril comment watch save
BreastfeedingPediatric

  • TRADE NAMES: Accupril (Pfizer); Accuprin; Accupro (Pfizer); Accuretic (Pfizer); Acuitel; Acupril; Asig; Korec; Quinazil
  • INDICATIONS: Hypertension; heart failure
  • CLASS: Angiotensin-converting enzyme (ACE) inhibitor, Antihypertensive, Vasodilator
  • HALF-LIFE: 2 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Alcohol, Aldesleukin, Allopurinol, Alpha blockers, Alprostadil, Amifostine, Amiloride, Angiotensin II receptor antagonists, Antacids, Antidiabetics, Antihypertensives, Antipsychotics, Anxiolytics and hypnotics, Aprotinin, Azathioprine, Baclofen, Beta blockers, Calcium channel blockers, Chlortetracycline, Ciprofloxacin, Clonidine, Corticosteroids, Cyclosporine, Demeclocycline, Diazoxide, Diuretics, Doxycycline, Eplerenone, Estrogens, Everolimus, Gemifloxacin, General anesthetics, Gold & Gold Compounds, Heparins, Hydralazine, Insulin, Levodopa, Lithium, Lymecycline, MAO inhibitors, Metformin, Methyldopa, Methylphenidate, Minocycline, Minoxidil, Moxifloxacin, Moxisylyte, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Ofloxacin, Oxytetracycline, Pentoxifylline, Phosphodiesterase 5 inhibitors, Potassium salts, Prostacyclin analogues, Quinine, Quinolones, Rituximab, Salicylates, Sirolimus, Spironolactone, Sulfonylureas, Temsirolimus, Tetracycline, Tetracyclines, Tigecycline, Tizanidine, Tolvaptan, Triamterene, Trimethoprim
  • PREGNANCY: category C in first trimester; category D in second and third trimesters
  • See adverse reactions attributed to class:

    Angiotensin-converting enzyme (ACE) inhibitor

    Antihypertensive

Contra-indicated in patients with a history of angioedema related to previous treatment with an ACE inhibitor.

FETAL TOXICITY

WHEN USED IN PREGNANCY DURING THE SECOND AND THIRD TRIMESTERS, ACE INHIBITORS CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS. WHEN PREGNANCY IS DETECTED, QUINAPRIL SHOULD BE DISCONTINUED AS SOON AS POSSIBLE.

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 08/21/2024

Saved Searches Watched Drugs
Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top
  • Help
  • Terms & Conditions
  • Privacy
  • Disclaimer
  • Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.